Trial Profile
: Pharmacokinetics of Ceftazidime-Avibactam in Critically Ill Patients With Renal Failure Requiring Continuous Venovenous Hemodiafiltration
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Nosocomial pneumonia; Urinary tract infections
- Focus Pharmacokinetics
- 08 Apr 2019 Planned End Date changed from 21 Oct 2019 to 21 Oct 2020.
- 08 Apr 2019 Planned primary completion date changed from 21 Mar 2019 to 21 Mar 2020.
- 17 Aug 2017 New trial record